Windlas Biotech Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹844.25
Market cap
1,779 Cr
Stock P/E
26.7
P/B
3.32
Dividend yield
0.6%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2023Jun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025
Sales141 Cr145 Cr153 Cr162 Cr171 Cr175 Cr187 Cr195 Cr203 Cr210 Cr222 Cr233 Cr
Operating expenses (approx.)124 Cr128 Cr134 Cr142 Cr149 Cr154 Cr164 Cr166 Cr177 Cr184 Cr194 Cr209 Cr
EBITDA16 Cr17 Cr19 Cr20 Cr22 Cr21 Cr23 Cr29 Cr26 Cr27 Cr29 Cr24 Cr
OPM %11.7%11.8%12.2%12.5%12.8%11.9%12.3%14.7%12.6%12.6%12.8%10.5%
Other income2 Cr3 Cr3 Cr3 Cr4 Cr4 Cr5 Cr4 Cr5 Cr5 Cr4 Cr5 Cr
Interest0.17 Cr0.24 Cr0.28 Cr0.30 Cr0.28 Cr0.49 Cr1 Cr1 Cr1 Cr1 Cr1 Cr1 Cr
Depreciation4 Cr3 Cr3 Cr3 Cr4 Cr6 Cr7 Cr7 Cr8 Cr7 Cr8 Cr8 Cr
Profit before tax15 Cr16 Cr18 Cr20 Cr23 Cr18 Cr20 Cr20 Cr21 Cr23 Cr24 Cr20 Cr
Tax %23.9%26.2%23.4%23.8%24.9%26.4%22.8%23.4%21.8%24.0%24.5%24.9%
Net profit11 Cr12 Cr14 Cr15 Cr17 Cr13 Cr16 Cr16 Cr16 Cr18 Cr18 Cr15 Cr
EPS (₹)₹5.37₹5.79₹6.75₹7.26₹8.17₹6.47₹7.49₹7.45₹7.77₹8.43₹8.48₹7.12

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025TTM
Sales466 Cr513 Cr631 Cr760 CrSign in for TTM
Operating expenses (approx.)414 Cr453 Cr553 Cr666 CrSign in for TTM
EBITDA52 Cr60 Cr78 Cr94 CrSign in for TTM
OPM %11.3%11.7%12.4%12.4%Sign in for TTM
Other income7 Cr10 Cr13 Cr18 CrSign in for TTM
Interest1 Cr0.79 Cr1 Cr4 CrSign in for TTM
Depreciation12 Cr12 Cr13 Cr28 CrSign in for TTM
Profit before tax46 Cr57 Cr77 Cr80 CrSign in for TTM
Tax %16.4%25.3%24.5%23.5%Sign in for TTM
Net profit38 Cr43 Cr58 Cr61 CrSign in for TTM
EPS (₹)₹18.80₹19.70₹27.97₹29.19Sign in for TTM
Dividend payout %0.0%17.9%14.3%18.8%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025
Equity capital11 Cr10 Cr10 Cr10 Cr
Reserves384 Cr392 Cr440 Cr495 Cr
Borrowings6 Cr0.44 Cr0.11 Cr27 Cr
Other liabilities90 Cr126 Cr176 Cr228 Cr
Total liabilities491 Cr529 Cr626 Cr760 Cr
Fixed assets (net)91 Cr103 Cr169 Cr195 Cr
CWIP8 Cr14 Cr6 Cr3 Cr
Investments65 Cr107 Cr173 Cr223 Cr
Other assets382 Cr354 Cr431 Cr525 Cr
Total assets491 Cr529 Cr626 Cr760 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2023Mar 2024Mar 2025
Cash from operating activity9 Cr61 Cr109 Cr68 Cr
Cash from investing-155 Cr-14 Cr-92 Cr-74 Cr
Cash from financing130 Cr-44 Cr-15 Cr1 Cr
Net cash flow-15 Cr3 Cr2 Cr-5 Cr
Free cash flow (OCF − Capex)-6 Cr-10 Cr71 Cr16 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2022Mar 2023Mar 2024Mar 2025
ROCE %10.0%11.9%14.4%12.4%
ROE %9.6%10.6%0.0%0.0%
Debtor days87837980
Inventory days6953766612725
Days payable75621621126149
Cash conversion cycle8174-8466-13344
Debt / equity0.020.00110.00020.05
Current ratio4.062.922.512.11
Net debt / EBITDA0.11-0.05-0.070.28

Compare with peers

Loading peers…